Search Results - Matthew I. Milowsky

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer by Blaine Brower, Asia McCoy, Hiba Ahmad, Cheryl Eitman, I. Alex Bowman, Jennifer Rembisz, Matthew I. Milowsky, Matthew I. Milowsky

    Published in Frontiers in Oncology (2024-04-01)
    Get full text
    Article


  2. 2

    Bladder preservation in muscle-invasive bladder cancer: a comprehensive review by Judy Hamad, Hannah McCloskey, Matthew I. Milowsky, Trevor Royce, Angela Smith

    Published in International Brazilian Journal of Urology (2020-02-01)
    Get full text
    Article


  3. 3

    PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion by Tämer El Saadany, Anja Lorch, Matthew I. Milowsky, Ursula Maria Vogl, Richard Cathomas

    Published in Frontiers in Oncology (2024-08-01)
    Get full text
    Article


  4. 4

    Metachronous Bilateral Testicular Leydig-Like Tumors Leading to the Diagnosis of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) by Josip Vukina, David D. Chism, Julie L. Sharpless, Mathew C. Raynor, Matthew I. Milowsky, William K. Funkhouser

    Published in Case Reports in Pathology (2015-01-01)
    Get full text
    Article


  5. 5

    A Case of Rapidly Progressive De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer by Aryan Dalal, Sean Clark-Garvey, Andrew Gdowski, Sophia Zhang, Sara E. Wobker, Steven P. Rowe, Ersan Altun, Himisha Beltran, Matthew I. Milowsky

    Published in Case Reports in Oncological Medicine (2024-01-01)
    Get full text
    Article


  6. 6

    Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and R... by Catherine C. Fahey, Sean Clark-Garvey, Sima Porten, Ashish M. Kamat, Thomas W. Flaig, John A. Taylor, William Y. Kim, Matthew I. Milowsky

    Published in Current Oncology (2025-05-01)
    Get full text
    Article


  7. 7

    Inflammatory myofibroblastic tumor in a patient with X-Linked hypophosphatemia: A case of Occam's razor or Hickam's dictum? by Farhan Chowdry, Kelsey M. Miller, Ersan Altun, Sara E. Wobker, Gary S. Gottesman, Hikmat Al-Ahmadie, Tracy L. Rose, Eric M. Wallen, Matthew I. Milowsky

    Published in Urology Case Reports (2024-05-01)
    Get full text
    Article


  8. 8

    Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications by Kristin Weiss, Kathryn H. Gessner, Alysen Demzik, Elizabeth Moreton, William Y. Kim, Sara E. Wobker, Tracy L. Rose, Matthew I. Milowsky, Marc A. Bjurlin

    Get full text
    Article


  9. 9

    Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer by Wolfgang Beckabir, Mi Zhou, Jin Seok Lee, Steven P. Vensko, Mark G. Woodcock, Hsing-Hui Wang, Sara E. Wobker, Gatphan Atassi, Alec D. Wilkinson, Kenneth Fowler, Leah M. Flick, Jeffrey S. Damrauer, Michael R. Harrison, Karen P. McKinnon, Tracy L. Rose, Matthew I. Milowsky, Jonathan S. Serody, William Y. Kim, Benjamin G. Vincent

    Published in Nature Communications (2024-05-01)
    Get full text
    Article


  10. 10

    Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule by Małgorzata A. Witek, Rachel D. Aufforth, Hong Wang, Joyce W. Kamande, Joshua M. Jackson, Swathi R. Pullagurla, Mateusz L. Hupert, Jerry Usary, Weiya Z. Wysham, Dawud Hilliard, Stephanie Montgomery, Victoria Bae-Jump, Lisa A. Carey, Paola A. Gehrig, Matthew I. Milowsky, Charles M. Perou, John T. Soper, Young E. Whang, Jen Jen Yeh, George Martin, Steven A. Soper

    Published in npj Precision Oncology (2017-07-01)
    Get full text
    Article


  11. 11

    FGFR inhibition augments anti–PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression by Atsushi Okato, Takanobu Utsumi, Michela Ranieri, Xingnan Zheng, Mi Zhou, Luiza D. Pereira, Ting Chen, Yuki Kita, Di Wu, Hyesun Hyun, Hyojin Lee, Andrew S. Gdowski, John D. Raupp, Sean Clark-Garvey, Ujjawal Manocha, Alison Chafitz, Fiona Sherman, Janaye Stephens, Tracy L. Rose, Matthew I. Milowsky, Sara E. Wobker, Jonathan S. Serody, Jeffrey S. Damrauer, Kwok-Kin Wong, William Y. Kim

    Published in The Journal of Clinical Investigation (2024-01-01)
    Get full text
    Article


  12. 12

    Treatment‐Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study by Amanda Nizam, Charles B. Nguyen, Jinju Li, Emily C. Zabor, Pavlos Msaouel, Cindy Y. Jiang, Omar Alhalabi, Eugene Oh, Matthew P. Davidsohn, Ilana B. Epstein, Dimitra Rafailia Bakaloudi, Rafee Talukder, Tanya Jindal, Amy K. Taylor, Michael J. Glover, Ali Raza Khaki, Emily Lemke, Hannah Mabey, Bashar Abuqayas, Albert Jang, Jason R. Brown, Sean T. Evans, Cameron Pywell, Arnab Basu, Mehmet A. Bilen, Pedro C. Barata, Yousef Zakharia, Matthew I. Milowsky, Deepak Kilari, Christopher J. Hoimes, Sumit A. Shah, Hamid Emamekhoo, Nancy B. Davis, Shilpa Gupta, Petros Grivas, Joaquim Bellmunt, Matthew T. Campbell, Ajjai S. Alva, Vadim S. Koshkin

    Published in Cancer Medicine (2025-10-01)
    Get full text
    Article


Search Tools: